Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Bhaskar C, Harinath"'
Autor:
Lingaraja Jena, Bhaskar C Harinath
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 2, Iss 1, Pp 16-19 (2018)
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the world. Increase in multidrug resistant, extensively drug-resistant, and totally drug-resistant cases of tuberculosis are causing concern to the health a
Externí odkaz:
https://doaj.org/article/e387ef9b2d0d41a5923eac89500bab15
Publikováno v:
International Journal of Mycobacteriology, Vol 7, Iss 1, Pp 61-68 (2018)
Background: The Mycobacterium tuberculosis (MTB) uridine diphosphogalactofuranose (UDP)-galactopyranose mutase (UGM) is an essential flavoenzyme for mycobacterial viability and an important component of cell wall. It catalyzes the interconversion of
Externí odkaz:
https://doaj.org/article/5b3da8f7afbf44f3925d1e4ce283aeac
Autor:
Gauri Wankhade, Sarika Kamble, Shraddha Deshmukh, Lingaraja Jena, Pranita Waghmare, Bhaskar C Harinath
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 1, Iss 1, Pp 49-54 (2017)
Background: Cholesterol degradation pathway is one of the important pathways in survival of Mycobacterium tuberculosis (Mtb) bacilli, and steroid C26-monooxygenase (CYP125) enzyme of Mtb associated with this pathway is reported to be novel drug targe
Externí odkaz:
https://doaj.org/article/8128e578c3ea4288b52e4a6b53be194a
Autor:
Bhaskar C Harinath
Publikováno v:
International Journal of Mycobacteriology, Vol 6, Iss 4, Pp 323-325 (2017)
Externí odkaz:
https://doaj.org/article/8ac8992942cd421c905b8aa807659229
Publikováno v:
International Journal of Mycobacteriology, Vol 4, Iss 4, Pp 276-283 (2015)
Objective/Background: Isoniazid (INH) is one of the effective antituberculosis (TB) drugs used for TB treatment. However, most of the drug-resistant Mycobacterium tuberculosis (MTB) clinical strains are resistant to INH, a first-line antituberculous
Externí odkaz:
https://doaj.org/article/ed4c998c7bc2484cbb6dcafc75820788
Publikováno v:
International Journal of Mycobacteriology, Vol 3, Iss 4, Pp 276-282 (2014)
Tuberculosis (TB) is an ancient disease caused by Mycobacterium tuberculosis (MTB), which remains a major cause for morbidity and mortality in several developing countries. Most drug-resistant MTB clinical strains are resistant to isoniazid (INH), a
Externí odkaz:
https://doaj.org/article/ebbd18d823c64d388953ba31996cfd7d
Autor:
Bhaskar C Harinath, Lingaraja Jena
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 2, Iss 1, Pp 85-86 (2018)
Externí odkaz:
https://doaj.org/article/74413db7f45e487dbc61a0830c5dbc8d
Publikováno v:
International Journal of Mycobacteriology, Vol 2, Iss 4, Pp 220-226 (2013)
Background: Mycobacterium tuberculosis (MTB) H37Ra is an attenuated tubercle bacillus closely related to the virulent type strain MTB H37Rv. In spite of extensive study, variation in virulence between the MTB H37Rv and MTB H37Ra strains is still to b
Externí odkaz:
https://doaj.org/article/0984cf5dfb8947289aeb07dc388e8be4
Autor:
Bhaskar C Harinath
Publikováno v:
International Journal of Mycobacteriology, Vol 5, Iss 5, Pp 86-87 (2016)
Objective/background: Tuberculosis (TB) has been declared as a global emergency by the World Health Organization in 1993 and still remains one of the world's biggest threats. Worldwide, 9.6 million people have been estimated to have fallen ill with T
Externí odkaz:
https://doaj.org/article/8502d98f01094ebf950a8149ddeb7cc8
Autor:
Lingaraja Jena, Bhaskar C Harinath
Publikováno v:
International Journal of Mycobacteriology, Vol 4, Iss 4, Pp 354-355 (2015)
Externí odkaz:
https://doaj.org/article/0b58141660034a50874977d6360145b8